Alzheimer's Association - Part the CloudFoundation
Alzheimer’s Association Part the Cloud - Enable the Molecule for Therapeutics (PTC-EMT) Funding Program
Award$100,000
Deadline2025-09-24T17:00:00-05:00
DifficultyComplex
Health & MedicineScience & Research
About this opportunity
- Grants for researchers at nonprofit academic institutions and small for-profit companies
- Focus on Alzheimer's and related dementias
- Projects must be at the IND-enabling stage of drug development (preparing for first-in-human clinical trials)
- Funding helps move promising therapies from advanced preclinical work to clinical trials
- Applicants must register and submit a Letter of Intent (LOI) before applying
- Supports studies like pharmacology, toxicology, biodistribution, formulation, and manufacturing scale-up
- Aims to speed up the development of new treatments for Alzheimer's and related dementias
Eligibility requirements
Applicants must be individuals at nonprofit academic institutions or small for-profit companies
Projects must focus on Alzheimer's or related dementias
Project must be at the IND-enabling stage of drug development
Applicants must register and submit a Letter of Intent (LOI)
How to apply
Registration as a new user (if first time)
Letter of Intent (LOI) submission
Full application after LOI approval
What you get
$100,000 grant
Support for IND-enabling research
Access to Alzheimer's Association resources
Full access
Unlock full grant details
See eligibility, application requirements, deadlines, and personalized match scores for this grant and hundreds more.